ARIAD Announces Webcast of Its Annual Shareholders Meeting

  ARIAD Announces Webcast of Its Annual Shareholders Meeting

Business Wire

CAMBRIDGE, Mass. -- June 13, 2013

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual
Meeting of Stockholders will be webcast live on June 20, 2013 and can be
accessed by visiting the investor relations section of the Company’s website
at: http://www.ariad.com/investor.

The annual meeting will take place at 10:00 a.m. (EDT) at the Company’s
offices in Cambridge, Massachusetts and will include an overview of ARIAD and
its key programs provided by Harvey J. Berger, M.D., chairman and chief
executive officer of ARIAD, and key members of senior management. A replay
will be available on the investor page of the ARIAD website approximately
three hours after the presentation and will be archived for four weeks. To
ensure a timely connection to the live webcast, participants should log on at
least five minutes prior to the scheduled start time.

About ARIAD

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and
Lausanne, Switzerland, is an integrated global oncology company focused on
transforming the lives of cancer patients with breakthrough medicines. ARIAD
is working on new medicines to advance the treatment of various forms of
chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines.
For additional information, visit http://www.ariad.com or follow ARIAD on
Twitter (@ARIADPharm).

Contact:

ARIAD Pharmaceuticals, Inc.
For Investors
Kendra Adams, 617-503-7028
kendra.adams@ariad.com
or
For Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com